Eli Lilly (LLY) missed Wall Street's revenue expectations in third quarter earnings released Wednesday morning, sending shares down as much as 10% in premarket trading. The drugmaker also slashed its profit guidance and the high end of its revenue outlook for the year. The company reported revenue of $11.4 billion, falling short of Wall Street estimates of $12.17 billion.
Open Flip
📌US equity futures rose on Wednesday, following a record high close for the Nasdaq, driven by stronger-than-expected earnings from Alphabet and solid gains from tech heavyweights. 📌The S&P 500 rose 0.16% and the Nasdaq scaled a fresh record peak as investors looked to key economic data. 📌Treasury yields, while still expressing concern for a resurgence inflation and higher debt and deficits.
Open Flip
Bunge exceeded Wall Street expectations for Q3 profit, driven by increased volumes in grain trading and oilseed processing, which offset lower margins. The company reiterated its full-year adjusted profit forecast of $9.25 per share, citing the current margin environment and loss of income from a joint venture sale.
Open Flip
